[HTML][HTML] Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy

G Fumagalli, L Monza, G Cavaletti, R Rigolio… - Frontiers in …, 2021 - frontiersin.org
Peripheral neuropathies are characterized by nerves damage and axonal loss, and they
could be classified in hereditary or acquired forms. Acquired peripheral neuropathies are …

Neuroinflammation and the generation of neuropathic pain

A Ellis, DLH Bennett - British journal of anaesthesia, 2013 - academic.oup.com
Inflammation is the process by which an organism responds to tissue injury involving both
immune cell recruitment and mediator release. Diverse causes of neuropathic pain are …

Interleukin-6: an emerging regulator of pathological pain

YQ Zhou, Z Liu, ZH Liu, SP Chen, M Li… - Journal of …, 2016 - Springer
Interleukin-6 is an inflammatory cytokine with wide-ranging biological effects. It has been
widely demonstrated that neuroinflammation plays a critical role in the development of …

[HTML][HTML] Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases

L Carniglia, D Ramírez, D Durand, J Saba… - Mediators of …, 2017 - hindawi.com
Microglial cells are responsible for immune surveillance within the CNS. They respond to
noxious stimuli by releasing inflammatory mediators and mounting an effective inflammatory …

Neuropathic pain and cytokines: current perspectives

AK Clark, EA Old, M Malcangio - Journal of pain research, 2013 - Taylor & Francis
Neuropathic pain represents a major problem in clinical medicine because it causes
debilitating suffering and is largely resistant to currently available analgesics. A …

[HTML][HTML] Neuropathic pain: delving into the oxidative origin and the possible implication of transient receptor potential channels

C Carrasco, M Naziroǧlu, AB Rodríguez… - Frontiers in …, 2018 - frontiersin.org
Currently, neuropathic pain is an underestimated socioeconomic health problem affecting
millions of people worldwide, which incidence may increase in the next years due to …

[HTML][HTML] Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy

JG Lees, PGS Makker, RS Tonkin, M Abdulla… - European journal of …, 2017 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) and associated neuropathic pain are
challenging complications of cancer treatment. Many of the major classes of …

Vincristine-induced peripheral neuropathy: a mini-review

G Li, Y Hu, D Li, Y Zhang, H Guo, Y Li, F Chen, J Xu - Neurotoxicology, 2020 - Elsevier
Vincristine (VCR), an alkaloid extracted from vinca, is often used in combination with other
chemotherapeutic drugs to treat a variety of cancers, such as acute lymphoblastic leukaemia …

Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1–dependent withdrawal

L Deng, J Guindon, BL Cornett, A Makriyannis… - Biological …, 2015 - Elsevier
Background Mixed cannabinoid receptor 1 and 2 (CB 1 and CB 2) agonists such as Δ 9-
tetrahydrocannabinol (Δ 9-THC) can produce tolerance, physical withdrawal, and unwanted …

Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury

SM Carlton, J Du, HY Tan, O Nesic, GL Hargett… - Pain®, 2009 - Elsevier
Central neuropathic pain (CNP) developing after spinal cord injury (SCI) is described by the
region affected: above-level, at-level and below-level pain occurs in dermatomes rostral …